View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, June 8 (HealthDay News) -- The A1C assay should be the definitive test to diagnose diabetes, according to a report presented at the American Diabetes Association's 69th Scientific Sessions, held from June 5 to 9 in New Orleans.
According to an international expert committee assembled by the American Diabetes Association, International Diabetes Federation, and European Association for the Study of Diabetes, the A1C assay may serve as a better marker than either the fasting plasma glucose test or the less commonly used oral glucose tolerance test.
After reviewing data which examined A1C levels and long-term complications of diabetes such as retinopathy, the committee concluded that an A1C value greater than or equal to 6.5 percent should be the cut-off point for diagnosing the disease.
"A1C values vary less than fasting plasma glucose values and the assay for A1C has technical advantages compared with the glucose assay," chair of the expert committee, David M. Nathan, M..D., of Massachusetts General Hospital and Harvard Medical School in Boston, said in a statement. "Also, testing for diabetes using A1C is more convenient and easier for patients who will no longer be required to perform a fasting or oral glucose tolerance test."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top